IP Library Granted Patent US 10,898,538
Granted Patent B2
US 10,898,538 · App. 15/253,358 · Granted Jan 26, 2021

Methods for maintaining pegylation of polypeptides

Inventors: Bernice Yeung (Lexington, MA); Jack Wang (Lexington, MA)
Assignee: BRISTOL-MYERS SQUIBB COMPANY
A61K38/02A61K47/60A61K47/6435C07K14/78
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,538
App. No.
15/253,358
Granted
Jan 26, 2021
Kind
B2
Abstract

Described herein are methods for maintaining PEGylation and inhibiting dePEGylation of polypeptides, such as fibronectin-based scaffold proteins, during storage.

Claims (11)

1. A method for maintaining PEGylation of polypeptides comprising a tenth fibronectin type III ( 10 Fn3) domain during storage, the method comprising storing the polypeptides in a solution buffered to a pH between pH 2.0 and pH 4.5, wherein the polypeptides are conjugated to a polyethylene glycol (PEG) moiety through a maleimide linker via site-directed PEGylation to a cysteine residue of the polypeptide, wherein less than 5% of the maleimide linkers are cleaved over a four week storage period, and wherein the C-terminal tail of the 10 Fn3 domain does not contain a DK sequence.

2. The method of claim 1 , wherein less than 5% of the maleimide linkers are cleaved over an eight week storage period.

3. The method of claim 1 , wherein the 10 Fn3 domain has an altered amino acid sequence relative to the wild-type sequence that binds to a target molecule with a K D of less than 500 nM.

4. The method of claim 1 , wherein the PEG moiety is attached to the cysteine residue on the C-terminal tail of the 10 Fn3 domain.

5. The method of claim 4 , wherein the maleimide linker forms a thioether bond with a sulfhydryl group on the cysteine residue of the polypeptide.

6. The method of claim 1 , wherein the pH of the solution is between 3.0 and 4.0.

7. The method of claim 1 , wherein the pH of the solution is between 3.5 and 4.5.

8. The method of claim 1 , wherein the concentration of the PEGylated polypeptides in the solution is from 1-10 mg/mL.

9. The method of claim 1 , wherein the PEGylated polypeptides are stored at a temperature from 4° C. to 30° C.

10. The method of claim 1 , wherein the buffer lacks sodium chloride.

11. The method of claim 1 , wherein the buffer is selected from the group consisting of: (a) 25 mM succinate and 5% sorbitol and (b) 10 mM sodium acetate and 5% mannitol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2020
From: YEUNG, BERNICE; WANG, JACK
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 053950/0837 →
Continuity (3)
Continuation 14117458
Provisional Application 61487027 · May 17, 2011
Related Publication 20170049905A1 · Feb 23, 2017